• Possible new therapy has been identified
    September 23, 2010 |  Research & Medicine

    Researchers at pharmaceutical company Genzyme and the University of Michigan have identified a possible new therapy. Compound Genz-123346, a specific inhibitor of the synthesis of GlyCer was tested in three cystic mouse models and showed a dose-dependent improvement in symptoms.



Subscribe
Categories
Archive
2012 (5)
February(2) 
January(3) 
2011 (75)
December(8) 
November(11) 
October(6) 
September(5) 
August(6) 
July(7) 
June(7) 
May(4) 
April(4) 
March(5) 
February(8) 
January(4) 
2010 (70)
December(6) 
November(11) 
October(3) 
September(9) 
August(6) 
July(6) 
June(10) 
May(6) 
April(3) 
March(7) 
February(1) 
January(2) 
2009 (19)
December(1) 
November(2) 
October(3) 
September(1) 
August(1) 
July(1) 
May(1) 
March(3) 
February(4) 
January(2) 
2008 (14)
December(1) 
May(1) 
April(2) 
March(6) 
February(2) 
January(2) 
 
©2010, PKD Foundation  · The PKD Foundation is a 501 (c)(3), 509 (a)(1) public charity.